Breast Cancer Group

Home Tag

Cristina Saura-8

SOLTI-TOT-HER3 window of opportunity trial: final results show that lower dose patritumab deruxtecan is less toxic and does not compromise efficacy in the treatment of breast cancer

Presented at the 2023 ESMO Breast Cancer Annual Congress, 11-13 May in Berlin, final results of the SOLTI-TOT-HER3 window of…

Cristina Saura-1_pp

POSITIVE results show that temporarily discontinuing endocrine therapy to attempt pregnancy after breast cancer does not increase the short-term risk of disease relapse

Published in The New England Journal of Medicine (1), first results of the international POSITIVE study co-authored by VHIO’s Cristina…

1 2